Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy
Status:
Active, not recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Diagnostic procedures, such as contrast-enhanced CT scan and contrast-enhanced
MRI, may help find liver cancer and find out how far the disease has spread.
PURPOSE: This clinical trial is studying contrast-enhanced CT scan and contrast-enhanced MRI
in diagnosing and staging liver cancer in patients with chronic liver disease.